Laddar...
Anti-TNF immunotherapy and tuberculosis reactivation: another mechanism revealed
Anti-TNF immunotherapy has revolutionized the treatment of some inflammatory diseases, such as RA. However, a major concern is that patients receiving this therapy have an increased risk of fungal and bacterial infection, particularly of reactivating latent tuberculosis (TB). In this issue of the JC...
Sparad:
| Huvudupphovsmän: | , |
|---|---|
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
American Society for Clinical Investigation
2009
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2673853/ https://ncbi.nlm.nih.gov/pubmed/19422095 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI39143 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|